The New York Attorney General filed a lawsuit against Actavis and Forest for pulling the old version of its Alzheimer’s treatment Naminda. In this interview with Bloomberg Radio, Professor Carrier explores the consequences of this development.
Category: News
Michael Carrier testifies to U.S. Senate committee
http://www.c-spanvideo.org/program/PatentS Michael Carrier testified before the U.S. Senate Judiciary Committee’s Subcommittee on Antitrust, Competition Policy and Consumer Rights at a hearing entitled “Pay-for-Delay Deals: Limiting Competition and Costing Consumers” that was televised on C-SPAN. He provided support for congressional legislation to address the problem of settlements by which brand-name drug companies pay generics to delay … Continue reading Michael Carrier testifies to U.S. Senate committee…
RIIPL welcomes our first visiting fellow, Dr. Tarlach McGonagle.
The Rutgers Institute for Information Policy and Law (RIIPL) welcomes its first visiting RIIPL Fellow, Dr. Tarlach McGonagle from the University of Amsterdam.Dr. Tarlach McGonagle specializes in a broad range of topics relating to international and European human rights law, especially the rights to freedom of expression and religion; minority rights; participatory rights, and cultural … Continue reading RIIPL welcomes our first visiting fellow, Dr. Tarlach McGonagle.…